AI ‘liquid biopsies’ using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer

AI Summary

This article discusses a study on using artificial intelligence to detect genetic changes and protein biomarkers in blood samples as a potential method for early detection of ovarian cancer in women. The AI "liquid biopsies" could aid in screening for this type of cancer.

A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a new study.

Leave a Reply